Recombinant Poinsettia latent virus Protein P2-P3 (ORF2/ORF3)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Poinsettia Latent Virus Protein P2-P3 (ORF2/ORF3)

The Recombinant Poinsettia latent virus Protein P2-P3 (ORF2/ORF3) is a genetically engineered protein derived from the Poinsettia latent virus (PnLV), which is a member of the genus Polemovirus. This virus is unique due to its chimeric nature, combining genetic features of both poleroviruses and sobemoviruses . The protein P2-P3 corresponds to the ORF2 and ORF3 regions of the viral genome, which are crucial for viral replication and structure .

Characteristics of Recombinant Poinsettia Latent Virus Protein P2-P3 (ORF2/ORF3)

  • Expression System: This recombinant protein is typically expressed in Escherichia coli (E. coli) .

  • Protein Length: The full-length mature protein spans from amino acids 417 to 1100 .

  • Tagging: The protein is often fused with an N-terminal His tag to facilitate purification .

  • Purity: The purity of the recombinant protein is generally greater than 90% as determined by SDS-PAGE .

  • Storage: It is recommended to store the protein at -20°C or -80°C to maintain stability .

Biological Significance of Poinsettia Latent Virus

Poinsettia latent virus is known for its asymptomatic infection in poinsettia plants (Euphorbia pulcherrima) worldwide. It is transmitted primarily through grafting and vegetative propagation, with its natural transmission method still unknown . The virus is of interest due to its unique genetic composition and potential implications for plant virology research.

4.1. Genome Organization

The PnLV genome consists of four open reading frames (ORFs). ORF1 encodes proteins with helicase, protease, and putative VPg domains. ORF2 is an RNA-dependent RNA polymerase, likely translated by frameshift from ORF1. ORF3 encodes the viral coat protein, translated from a subgenomic RNA .

4.2. Recombinant Protein Applications

Recombinant proteins like P2-P3 are valuable tools for studying viral replication mechanisms, developing diagnostic assays, and potentially designing novel antiviral strategies. They can also serve as antigens for immunological studies.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
ORF2/ORF3; Protein P2-P3
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
417-1100
Protein Length
Full Length of Mature Protein
Species
Poinsettia latent virus (isolate Euphorbia pulcherrima/Germany/Siepen/2005) (PnLV) (Poinsettia cryptic virus)
Target Names
ORF2/ORF3
Target Protein Sequence
TTNVRGNLYNDEGFRLSVGEDDKAEHWTDRLMKSITFKTKRWADWAEEESESDDERGKVV PPAKPSNYGEGCPPEHNQYLSDVGDLLTKVIGPEQNEKCVDILMGIMGVDKNEVAPHKEE KAEKGKRSSGFGHGKNRKGTNHPMRRGYNFRNCKKGGGQDESESHREISGRDPGRESNDK SPQGEAEEFERYFSSFYSWKLHNSGEANSGFRPCGKIPKFYRPRKRRVSEWGQNLARKHS SLGEITQGFGWPEAGAEAELRSLRLQAQRWLERSKSSVIPSAIEREIVISRLVESYKICR SEAPLCSSGSDLSWKGFLEDFREAVSSLELDAGIGVPYIGYGYPTHRGWVENPRLLPVLS RLVYARLQRLATLSVDGKTPEELVRDGLVDPVRVFVKGEPHKQSKLDEGRYRLIMSVSLI DQLVARVLFQKQNKLELLLWRSIPSKPGFGLSTVEQVEEFIDHLARVVDVKSDDLLENWR ELMVPTDCSGFDWSVSDWMLKDEMEVRNRLTINCNDLTRRLRNSWLYCLSNSDLALSDGS LLAQEVPGVQKSGSYNTSSTNSRIRVMAAYFAGASWAVAIGDDALESIDTTLAVYKSLGF KVEVSEDLEFCSHIFKTRSLAIPVNTSKMLYRLIYGYEPECGNLDVLRNYLCALASVLHE LRHDQDLVQNLSKWLIPDGSQKIS
Uniprot No.

Target Background

Function
This protein is a precursor potentially yielding RNA-dependent RNA polymerase (RdRp), a crucial enzyme in viral replication. RdRp replicates the viral genome.
Database Links

KEGG: vg:7040108

Protein Families
SsRNA positive-strand viruses RNA-directed RNA polymerase family
Subcellular Location
Host membrane; Multi-pass membrane protein.

Q&A

What is Poinsettia latent virus and how is it classified taxonomically?

Poinsettia latent virus (PnLV), formerly named Poinsettia cryptic virus, is a chimeric virus with unique genetic characteristics. Research using virus-purification, immunological techniques, electron microscopy, cloning, and sequencing has demonstrated that PnLV contains a 4652 base plus-strand RNA genome that shows relationships to both poleroviruses and sobemoviruses . Specifically, the first three-quarters of its genome resembles poleroviruses, while the last quarter is more closely related to sobemoviruses .

Due to this hybrid nature, researchers have proposed classifying PnLV as a "polemovirus," representing its chimeric characteristics . The virus forms stable icosahedral particles approximately 34 nm in diameter, consistent with structural features of both viral families it relates to . Despite its worldwide distribution in commercial cultivars of Euphorbia pulcherrima (poinsettia), PnLV infection does not induce visible symptoms in host plants, making it a true latent virus rather than a cryptic virus as originally thought .

What functional roles does the P2-P3 protein play in the viral life cycle?

The P2-P3 protein plays critical roles in the Poinsettia latent virus life cycle, functioning primarily in viral genome replication and processing. Based on sequence similarities to poleroviruses and sobemoviruses, the protein's functions can be categorized as follows:

  • Replication Complex Formation: The RNA-directed RNA polymerase (RdRp) component (from ORF3) is essential for viral genome replication, synthesizing both negative-sense RNA intermediates and positive-sense genomic RNA .

  • Proteolytic Processing: The serine protease activity (from ORF2) is involved in cleaving viral polyproteins into functional units necessary for replication complex assembly .

  • Host Interaction: While specific host interactions are not fully characterized, the protein likely interacts with host factors to establish replication complexes and evade host defense mechanisms, as is typical of related viruses.

The protein functions as part of the viral replication mode that resembles poleroviruses, as suggested by similarities in protein and nucleic acid sequences at the 5' and extreme 3' end of the viral RNA . Understanding these functional roles provides insights into potential targets for virus inhibition and opportunities for using the virus as a model system or vector.

How should researchers prepare and reconstitute recombinant P2-P3 protein for experimental use?

Proper preparation and reconstitution of recombinant Poinsettia latent virus P2-P3 protein is critical for maintaining its structural integrity and functional properties. Based on established protocols, researchers should follow these methodological steps:

  • Initial Handling:

    • Briefly centrifuge the vial prior to opening to bring contents to the bottom

    • Work in a sterile environment to prevent contamination

  • Reconstitution Procedure:

    • Reconstitute the lyophilized protein in deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL

    • For long-term storage, add glycerol to a final concentration of 5-50% and aliquot the solution

  • Storage Recommendations:

    • Store working aliquots at 4°C for up to one week

    • For extended storage, keep at -20°C/-80°C

    • Avoid repeated freeze-thaw cycles as this significantly degrades protein quality

  • Quality Assessment:

    • Verify protein purity using SDS-PAGE (should be greater than 90%)

    • Consider conducting activity assays specific to the serine protease or RNA-directed RNA polymerase functions before experimental use

The protein is typically supplied in a Tris/PBS-based buffer containing 6% Trehalose at pH 8.0 . This formulation helps maintain protein stability during storage. When designing experiments, researchers should account for the buffer components and adjust experimental conditions accordingly to avoid interference with downstream applications.

What expression systems are most effective for producing recombinant P2-P3 protein, and what are their comparative advantages?

Different expression systems offer distinct advantages for producing recombinant Poinsettia latent virus P2-P3 protein, with selection depending on research objectives. Below is a methodological comparison of the primary expression systems:

Expression SystemAdvantagesLimitationsPurification TagsYieldApplications
E. coli- Rapid production
- High yield
- Cost-effective
- Well-established protocols
- Limited post-translational modifications
- Potential inclusion body formation
- Endotoxin concerns
His-tag (N-terminal) High- Structural studies
- Antibody production
- Initial characterization
Baculovirus/Sf9 cells- Enhanced protein folding
- Post-translational modifications
- Better solubility
- Higher cost
- Longer production time
- More complex protocols
Various options (His, GST)Moderate- Functional studies
- Protein-protein interactions
- Enzymatic assays
Yeast systems- Post-translational modifications
- Secretion capability
- Scalable
- Hyper-glycosylation
- Codon usage differences
Multiple optionsModerate to high- Large-scale production
- Functional studies

Currently, E. coli is the predominant system used for expressing recombinant P2-P3 protein as evidenced by commercial preparations . This bacterial expression system has been optimized to produce the full-length mature protein (amino acids 417-1100) with an N-terminal His-tag .

For researchers requiring proteins with native-like post-translational modifications or improved solubility, insect cell expression systems might be preferable, drawing from methodologies used for similar viral proteins such as those from Hepatitis E virus . When selecting an expression system, researchers should consider their downstream applications and the specific protein characteristics required for their experiments.

What are the optimal conditions for storage and maintaining stability of the P2-P3 protein?

Maintaining stability of recombinant Poinsettia latent virus P2-P3 protein requires careful attention to storage conditions. Based on established protocols, the following methodological approaches are recommended:

  • Temperature Management:

    • Store stock solutions at -20°C/-80°C for long-term storage

    • Keep working aliquots at 4°C for up to one week

    • Avoid room temperature storage for extended periods

  • Buffer Composition:

    • Optimal storage buffer: Tris/PBS-based buffer with 6% Trehalose, pH 8.0

    • For extended stability, adjust glycerol content to 50%

    • Maintain pH between 7.5-8.5 to prevent protein denaturation

  • Aliquoting Strategy:

    • Prepare single-use aliquots to avoid repeated freeze-thaw cycles

    • Use small volume aliquots (20-50 μL) to minimize waste

    • Use sterile microcentrifuge tubes with secure seals

  • Stability Monitoring:

    • Periodically check protein activity and integrity

    • Signs of degradation include precipitation, color change, or decreased activity

    • Establish quality control checkpoints using SDS-PAGE or functional assays

  • Special Considerations:

    • When using His-tagged protein, avoid high concentrations of chelating agents

    • Protect from light if photosensitive components are present in the buffer

    • Consider adding protease inhibitors if degradation is observed

Following these methodological recommendations will help maintain protein integrity and ensure reproducibility across experiments. The critical factors affecting stability are temperature fluctuations and freeze-thaw cycles, which should be minimized through proper laboratory practices .

How can researchers use the P2-P3 protein to study viral replication mechanisms?

The P2-P3 protein offers valuable opportunities for investigating viral replication mechanisms through several methodological approaches:

  • In Vitro Replication Assays:

    • Establish cell-free systems using purified P2-P3 protein to study RNA synthesis

    • Develop template-dependent polymerase assays to measure the RNA-directed RNA polymerase activity

    • Analyze the kinetics of RNA synthesis using radiolabeled or fluorescently tagged nucleotides

  • Structure-Function Analysis:

    • Conduct site-directed mutagenesis of conserved motifs within the P2-P3 protein

    • Map functional domains by creating truncated versions of the protein

    • Correlate structural features with enzymatic activities

  • Host Factor Identification:

    • Perform protein-protein interaction studies using techniques such as:

      • Co-immunoprecipitation with P2-P3 to identify binding partners

      • Yeast two-hybrid screening against host cDNA libraries

      • Proximity labeling approaches (BioID, APEX) to identify transient interactions

    • Validate identified host factors through functional knockdown/knockout studies

  • Comparative Virology Approaches:

    • Compare the replication mechanisms of Poinsettia latent virus with related poleroviruses and sobemoviruses

    • Investigate the chimeric nature of the virus to understand evolutionary adaptation

    • Explore how the unique genomic organization influences replication efficiency

  • Replication Complex Visualization:

    • Use immunofluorescence microscopy to localize P2-P3 protein in infected cells

    • Employ electron microscopy to visualize replication complexes

    • Implement live-cell imaging with fluorescently tagged P2-P3 to monitor dynamics

These methodological approaches can help elucidate the unique replication mechanisms of Poinsettia latent virus, particularly how its chimeric nature between poleroviruses and sobemoviruses influences its replication strategy . Understanding these mechanisms not only advances our knowledge of this specific virus but also provides insights into the broader field of positive-strand RNA virus replication.

What are the most effective techniques for studying P2-P3 protein-host interactions?

Investigating P2-P3 protein-host interactions requires sophisticated methodological approaches that can identify and characterize both stable and transient interactions. Researchers should consider these advanced techniques:

  • Affinity Purification-Mass Spectrometry (AP-MS):

    • Use His-tagged P2-P3 protein as bait to isolate interacting host proteins

    • Implement SILAC (Stable Isotope Labeling with Amino acids in Cell culture) for quantitative comparison

    • Apply computational filtering against common contaminants to identify specific interactions

    • Validate key interactions through reciprocal pull-downs

  • Proximity-Based Labeling:

    • Fuse BioID or APEX2 to P2-P3 protein for in vivo proximity labeling

    • Identify proteins within the microenvironment of P2-P3 during viral replication

    • Compare interactomes across different cellular compartments and time points

  • Structural Biology Approaches:

    • Apply X-ray crystallography or cryo-EM to determine structures of P2-P3 complexes with host proteins

    • Use NMR for mapping interaction interfaces of smaller domains

    • Implement hydrogen-deuterium exchange mass spectrometry (HDX-MS) to identify conformational changes upon binding

  • Functional Genomics Screens:

    • Conduct genome-wide CRISPR screens to identify host factors essential for P2-P3 function

    • Implement RNA interference screens targeting specific cellular pathways

    • Validate hits through complementation studies and direct interaction assays

  • Advanced Imaging Techniques:

    • Apply Förster Resonance Energy Transfer (FRET) to study protein-protein interactions in living cells

    • Use Fluorescence Correlation Spectroscopy (FCS) to measure binding kinetics in real-time

    • Implement super-resolution microscopy to visualize interaction complexes below the diffraction limit

  • Protein-RNA Interaction Studies:

    • Perform CLIP-seq (Cross-Linking Immunoprecipitation followed by sequencing) to identify RNA targets

    • Map RNA binding domains through truncation analysis and mutational studies

    • Characterize RNA-protein complexes using electrophoretic mobility shift assays (EMSA)

When designing these studies, researchers should consider drawing methodological parallels from studies of similar viral proteins, such as those conducted with Hepatitis E virus ORF2 and ORF3 proteins , while acknowledging the unique properties of the Poinsettia latent virus P2-P3 protein. These approaches collectively provide a comprehensive toolkit for dissecting the complex interactions between viral proteins and host cellular machinery.

How can researchers develop and validate antibodies against P2-P3 protein for immunological studies?

Developing and validating high-quality antibodies against Poinsettia latent virus P2-P3 protein requires a systematic methodological approach to ensure specificity and sensitivity. Researchers should follow these steps:

  • Antigen Design and Preparation:

    • Identify immunogenic regions within the P2-P3 protein using epitope prediction software

    • Consider both full-length protein (aa 417-1100) and strategic peptide fragments

    • Express recombinant protein with appropriate tags (His-tag commonly used)

    • Ensure high purity (>90%) of antigen by rigorous purification

  • Antibody Production Strategy:

    Antibody TypeAdvantagesProduction MethodTimelineApplications
    Polyclonal- Recognizes multiple epitopes
    - Robust signal
    - Quick production
    - Immunization of rabbits/goats
    - Affinity purification
    2-3 months- Western blot
    - IP
    - IHC
    Monoclonal- High specificity
    - Consistent production
    - Reduced background
    - Hybridoma technology
    - Recombinant expression
    4-6 months- All applications
    - Conformational epitopes
    - Quantitative assays
    Recombinant- Defined binding sites
    - No batch variation
    - Engineerable properties
    - Phage/yeast display
    - Synthetic libraries
    3-5 months- Specialized applications
    - Therapeutic development
  • Validation Protocol:

    • Specificity Testing:

      • Western blot against recombinant protein and viral lysates

      • Immunoprecipitation followed by mass spectrometry

      • Competitive ELISA with purified protein

      • Testing against related viral proteins to confirm specificity

    • Sensitivity Assessment:

      • Titration experiments to determine detection limits

      • Comparison with commercial antibodies if available

      • Evaluation across multiple applications (ELISA, IHC, IF)

    • Functional Validation:

      • Neutralization assays if applicable

      • Ability to detect native vs. denatured protein

      • Epitope mapping using truncated constructs or peptide arrays

  • Application-Specific Optimization:

    • Optimize antibody concentration for each application

    • Determine optimal buffer conditions and blocking agents

    • Establish positive and negative controls for each experiment

Taking methodological cues from antibody development against similar viral proteins, such as the work done with Hepatitis E virus ORF2 and ORF3 proteins , researchers can develop a panel of antibodies targeting different epitopes within the P2-P3 protein. This approach enables comprehensive immunological studies of Poinsettia latent virus infection dynamics and protein interactions.

What are common challenges when working with P2-P3 protein and how can they be addressed?

Researchers working with Poinsettia latent virus P2-P3 protein often encounter several technical challenges. Here are methodological approaches to address these issues:

  • Protein Solubility Issues:

    • Challenge: The P2-P3 protein may form aggregates or show limited solubility due to its large size (aa 417-1100) .

    • Solutions:

      • Optimize buffer conditions (pH 7.5-8.5, 150-300 mM NaCl)

      • Add solubility enhancers such as 0.1% Triton X-100 or low concentrations of urea

      • Express protein domains separately rather than full-length protein

      • Consider fusion tags beyond His-tag, such as GST or MBP for enhanced solubility

  • Protein Activity Loss:

    • Challenge: Loss of enzymatic activity (serine protease, RNA-directed RNA polymerase) during purification or storage .

    • Solutions:

      • Add stabilizing agents like glycerol (up to 50%) or trehalose (6%)

      • Maintain reducing environment with DTT or β-mercaptoethanol

      • Establish activity assays to monitor function throughout purification

      • Store protein at -80°C in single-use aliquots to minimize freeze-thaw cycles

  • Protein-Protein Interaction Specificity:

    • Challenge: Distinguishing specific interactions from non-specific binding.

    • Solutions:

      • Include stringent controls (unrelated proteins with similar properties)

      • Perform dose-response experiments with varying salt concentrations

      • Validate interactions using multiple orthogonal techniques

      • Consider crosslinking approaches to capture transient interactions

  • Structural Analysis Difficulties:

    • Challenge: Obtaining structural information due to protein flexibility or heterogeneity.

    • Solutions:

      • Focus on stable domains identified through limited proteolysis

      • Use complementary structural techniques (X-ray, NMR, cryo-EM)

      • Consider protein engineering to remove disordered regions

      • Analyze protein in complex with binding partners to stabilize structure

  • Reproducibility Issues:

    • Challenge: Batch-to-batch variation in protein preparations.

    • Solutions:

      • Establish rigorous quality control metrics (purity, activity)

      • Standardize expression and purification protocols

      • Create master cell banks for consistent starting material

      • Implement detailed record-keeping of all parameters affecting protein quality

By anticipating these challenges and implementing these methodological solutions, researchers can improve the reliability and reproducibility of experiments involving the Poinsettia latent virus P2-P3 protein. Drawing from experiences with similar viral proteins, such as those from Hepatitis E virus , can provide additional insights into optimizing experimental protocols.

How should researchers design experiments to study the enzymatic activities of P2-P3 protein?

Designing robust experiments to study the dual enzymatic activities of the Poinsettia latent virus P2-P3 protein (serine protease and RNA-directed RNA polymerase ) requires careful methodological considerations:

  • Serine Protease Activity Assays:

    Assay TypeMethodologyReadoutAdvantagesLimitations
    Fluorogenic SubstrateUse peptide substrates with fluorogenic leaving groupsFluorescence increaseHigh sensitivity, real-time kineticsMay not reflect natural substrate specificity
    FRET-Based AssaysDesign substrates with FRET pairs flanking cleavage siteFRET signal changeMonitors cleavage in real-timeComplex substrate design
    Western BlotIncubate with potential substrates and analyze cleavage productsBand pattern changesDetects natural substrate processingSemi-quantitative, endpoint
    Mass SpectrometryIdentify cleavage sites in complex protein mixturesPeptide mass fingerprintingIdentifies novel substrates and precise cleavage sitesRequires specialized equipment

    Experimental Controls:

    • Include protease inhibitors (PMSF, AEBSF) as negative controls

    • Use mutated catalytic residues (identified through sequence alignment) as inactive controls

    • Test pH and temperature optima to establish reaction conditions

  • RNA-Directed RNA Polymerase (RdRp) Activity Assays:

    Assay TypeMethodologyReadoutAdvantagesLimitations
    Template-Dependent RNA SynthesisSupply RNA templates and NTPsIncorporation of labeled nucleotidesDirect measurement of polymerase activityComplex assay setup
    Real-Time RNA SynthesisMonitor synthesis using fluorescent nucleotidesFluorescence intensityKinetic measurements possiblePotential interference with enzyme activity
    Primer ExtensionUse short primers with defined RNA templatesExtension product lengthSimple setup, clear readoutLimited to specific template sequences
    Terminal Transferase ActivityMeasure non-templated nucleotide additionProduct length increaseSimple assayMay not reflect actual RdRp function

    Experimental Controls:

    • Include known RdRp inhibitors (nucleoside analogs) as negative controls

    • Use mutated GDD motif (catalytic site) as inactive enzyme control

    • Test divalent cation requirements (Mg²⁺, Mn²⁺) for optimal activity

  • Integrated Experimental Design Considerations:

    • Domain Mapping: Create truncated constructs to isolate individual enzymatic domains

    • Structure-Function Analysis: Correlate enzymatic activities with structural elements

    • Substrate Specificity: Determine sequence preferences for both enzymatic activities

    • Regulation Mechanisms: Investigate how one enzymatic activity might influence the other

    • Host Factor Requirements: Identify host proteins that enhance or inhibit enzymatic activities

  • Advanced Approaches:

    • Single-Molecule Techniques: Monitor individual enzyme molecules to detect mechanistic heterogeneity

    • High-Throughput Screening: Develop miniaturized assays for inhibitor discovery

    • Cryo-EM Studies: Capture different conformational states during catalytic cycles

By implementing these methodological approaches, researchers can comprehensively characterize the enzymatic functions of the P2-P3 protein, which is critical for understanding its role in viral replication and potentially developing targeted antiviral strategies. The experimental design should account for the chimeric nature of Poinsettia latent virus, incorporating insights from both polerovirus and sobemovirus research .

What quality control methods should be implemented when working with recombinant P2-P3 protein?

Implementing rigorous quality control methods is essential when working with recombinant Poinsettia latent virus P2-P3 protein to ensure experimental reproducibility and reliable data interpretation. Researchers should establish the following comprehensive quality control protocol:

  • Purity Assessment:

    • SDS-PAGE Analysis: Verify protein purity exceeds 90% as standard practice

    • Size Exclusion Chromatography: Evaluate monodispersity and detect aggregation

    • Mass Spectrometry: Confirm protein identity and detect post-translational modifications or truncations

    • Densitometry Analysis: Quantify purity percentage using gel analysis software

  • Identity Verification:

    • Western Blotting: Confirm identity using anti-His antibodies (for His-tagged protein) or specific anti-P2-P3 antibodies

    • Peptide Mass Fingerprinting: Verify sequence coverage through tryptic digestion and MS analysis

    • N-terminal Sequencing: Confirm the correct start of the protein sequence

    • Immunological Detection: Use antibodies against different epitopes to confirm full-length protein

  • Functional Characterization:

    • Serine Protease Activity: Measure catalytic efficiency using synthetic substrates

    • RNA Polymerase Activity: Assess template-dependent RNA synthesis capacity

    • Thermal Shift Assay: Determine protein stability and proper folding

    • Circular Dichroism: Evaluate secondary structure composition

  • Contaminant Testing:

    Contaminant TypeDetection MethodAcceptable LimitsMitigation Strategy
    Endotoxin (for E. coli expressed protein) LAL assay or reporter cell assay<1 EU/mg proteinAdditional purification steps (e.g., Triton X-114 extraction)
    Host Cell ProteinELISA or MS-based methods<100 ppmOptimize purification protocol
    DNA/RNAAbsorbance ratio (A260/A280)Ratio <0.7DNase/RNase treatment during purification
    AggregatesDynamic light scattering<10%Optimize buffer conditions or filtration
    Metal ionsICP-MSElement-specific limitsEDTA treatment followed by dialysis
  • Stability Monitoring:

    • Accelerated Stability Studies: Evaluate protein degradation under stress conditions

    • Real-Time Stability: Monitor activity over time at different storage temperatures

    • Freeze-Thaw Stability: Assess impact of multiple freeze-thaw cycles on protein activity

    • pH and Temperature Profiling: Determine optimal conditions for maintaining stability

  • Batch Consistency Measures:

    • Certificate of Analysis: Document key parameters for each production batch

    • Reference Standards: Establish internal reference material for comparison

    • Trend Analysis: Track quality parameters across multiple batches over time

    • Product Specification: Define acceptance criteria for release testing

Implementation of these quality control methods will ensure that experiments using recombinant P2-P3 protein yield reliable and reproducible results. Particularly important is the verification of proper folding and enzymatic activity, as these are critical for functional studies of this multifunctional viral protein. Researchers should maintain detailed records of quality control results to facilitate troubleshooting and ensure experimental reproducibility.

How can the unique chimeric nature of Poinsettia latent virus inform evolutionary studies of viral recombination?

The chimeric nature of Poinsettia latent virus offers a valuable model system for studying viral evolution through recombination. Researchers can explore this unique characteristic through several methodological approaches:

  • Comparative Genomic Analysis:

    • Conduct whole-genome alignments between PnLV and related poleroviruses and sobemoviruses

    • Identify precise recombination breakpoints using specialized algorithms (RDP4, SimPlot)

    • Analyze sequence conservation patterns in P2-P3 protein regions derived from different viral ancestors

    • Map functional domains to evolutionary origins to understand selective pressures

  • Phylogenetic Reconstruction:

    • Generate gene-specific phylogenies for different regions of the P2-P3 protein

    • Implement Bayesian evolutionary analysis to estimate divergence times

    • Apply reconciliation methods to resolve incongruent evolutionary histories

    • Construct networks rather than trees to visualize reticulate evolution

  • Functional Evolution Studies:

    • Create chimeric constructs with domains from related viruses to test functional compatibility

    • Evaluate enzymatic activities of ancestral sequence reconstructions

    • Measure fitness effects of artificial recombination events in cellular models

    • Identify compensatory mutations that maintain protein function after recombination

  • Structural Biology Approaches:

    • Determine how the chimeric protein maintains structural integrity despite diverse origins

    • Identify interface regions between domains derived from different viral ancestors

    • Compare structural flexibility in regions with different evolutionary histories

    • Model the structural evolution of the protein using molecular dynamics simulations

  • Experimental Evolution:

    • Subject the virus to selection pressures in laboratory settings to observe recombination

    • Monitor genomic stability of the chimeric regions over multiple passages

    • Create synthetic chimeric viruses to test evolutionary hypotheses

    • Evaluate the role of host factors in promoting or constraining recombination

The unique classification of PnLV as a proposed "polemovirus" reflects its evolutionary history as a chimeric virus with characteristics of both poleroviruses and sobemoviruses . This natural experiment in viral evolution provides insights into how recombination contributes to viral diversity and adaptation. By studying the functional integration of domains from different viral origins within the P2-P3 protein, researchers can better understand the constraints and opportunities provided by recombination in RNA virus evolution.

What potential applications exist for using P2-P3 protein in biotechnology and molecular biology?

The unique properties of Poinsettia latent virus P2-P3 protein present several innovative applications in biotechnology and molecular biology. Researchers can explore these potential uses through the following methodological approaches:

  • Viral Vector Development:

    • Engineer PnLV-based vectors for plant biotechnology applications

    • Exploit the virus's latent (asymptomatic) infection properties for minimal impact on host plants

    • Utilize the RNA-dependent RNA polymerase domain for controlled replication

    • Develop chimeric vectors combining advantageous properties from poleroviruses and sobemoviruses

  • Enzyme Technology Applications:

    • Harness the serine protease domain for specialized proteolytic applications

    • Develop sequence-specific RNA polymerase tools from the RdRp domain

    • Create engineered variants with enhanced stability or altered specificity

    • Exploit the chimeric nature to design enzymes with novel functionalities

  • Protein Interaction Scaffolds:

    • Design protein interaction modules based on P2-P3 binding domains

    • Develop screening systems using P2-P3 protein fragments as bait

    • Create biosensors that utilize P2-P3 conformational changes upon binding

    • Engineer split-protein complementation systems for detecting protein-protein interactions

  • Structural Biology Tools:

    • Use the stable icosahedral structure as a nanoparticle platform

    • Develop protein crystallization chaperones based on well-folding domains

    • Create fusion proteins for cryoEM studies of challenging target proteins

    • Design molecular switches based on conformational changes in P2-P3

  • Diagnostic Applications:

    ApplicationMethodologyAdvantagesDevelopment Stage
    ImmunodiagnosticsDevelop antibodies against P2-P3 epitopesHigh specificity for PnLV detectionRequires antibody development
    Molecular DetectionDesign primers/probes targeting P2-P3 sequenceSensitive nucleic acid detectionCurrently feasible
    BiosensorsEngineer P2-P3 protein domains with reporter functionsReal-time monitoringEarly research
    Point-of-care TestingDevelop lateral flow assays using P2-P3 antibodiesRapid field detectionProof-of-concept
  • Educational Research Tools:

    • Develop biochemistry teaching kits featuring the dual-function protein

    • Create recombinant protein expression case studies based on P2-P3

    • Use the chimeric nature to illustrate viral evolution concepts

    • Design laboratory exercises demonstrating enzyme kinetics and specificity

The unique characteristics of Poinsettia latent virus as a chimeric virus make its P2-P3 protein particularly valuable for applications requiring specialized enzymatic activities or novel protein interactions. Its classification between poleroviruses and sobemoviruses provides opportunities to develop biotechnology tools with hybrid functionalities. As research on this protein continues, additional applications are likely to emerge, particularly in plant biotechnology and enzyme engineering fields.

How might research on P2-P3 protein contribute to understanding broader principles in virology?

Research on Poinsettia latent virus P2-P3 protein has significant potential to advance fundamental virological principles through several key research directions:

  • Viral Genome Organization and Expression:

    • Investigate how the chimeric genome organization influences coordinated gene expression

    • Study polyprotein processing strategies that maintain proper stoichiometry of viral components

    • Examine the regulation mechanisms between overlapping reading frames (ORF2/ORF3)

    • Analyze how compact viral genomes efficiently encode multiple protein functions

  • Evolution of Viral Replication Strategies:

    • Explore how the virus combines replication elements from poleroviruses and sobemoviruses

    • Investigate the functional compatibility between replication components of different viral origins

    • Study how chimeric viruses optimize replication efficiency while maintaining genome integrity

    • Develop models for the evolution of viral replication complexes through module exchange

  • Host-Range Determinants and Adaptation:

    • Identify specific domains within P2-P3 that determine host specificity

    • Study how the virus maintains latent infection in poinsettia without inducing symptoms

    • Investigate host factors that interact with P2-P3 to facilitate replication

    • Compare adaptive strategies between PnLV and related viruses with different host ranges

  • Viral Protein Multifunctionality:

    • Characterize how single viral proteins can perform multiple essential functions

    • Map functional domains within P2-P3 and identify regions of functional overlap

    • Study how conformational changes regulate different activities of the protein

    • Develop models for the evolution of multifunctional viral proteins

  • Viral Taxonomy and Classification Principles:

    • Examine how chimeric viruses challenge traditional taxonomic boundaries

    • Contribute to the proposed "polemovirus" classification criteria

    • Develop frameworks for classifying recombinant viruses with mixed characteristics

    • Create computational tools for predicting functional compatibility in chimeric viral proteins

  • Virus-Host Coevolution:

    • Study long-term evolutionary dynamics between PnLV and its poinsettia host

    • Investigate whether the latent infection represents a form of evolutionary accommodation

    • Compare selective pressures on different domains of P2-P3 based on host interaction

    • Develop models for predicting emerging viral threats through recombination events

The unique position of Poinsettia latent virus as a chimeric entity between poleroviruses and sobemoviruses makes it an excellent model system for studying fundamental principles of viral evolution, adaptation, and host interaction. The P2-P3 protein, with its dual enzymatic functions and complex evolutionary history, provides a unique window into how viruses optimize their genetic material through recombination while maintaining functional integrity. This research has broader implications for understanding viral emergence and the fundamental principles that govern viral evolution across taxonomic boundaries.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.